Context Therapeutics Inc. (CNTX) stock
CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.18−0.02 (-8.69%)
Close on Nov 13, 2026Market cap $16.61MP/E –Yield –
Context Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Context Therapeutics's total assets was $36.54M at Sep 30, 2026. For fiscal 2025 it was $68.49M, down 30.2% from the year before. The highest annual figure on record is $98.13M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $68.49M | -30.2% |
| FY2024 | Dec 31, 2024 | $98.13M | +510.9% |
| FY2023 | Dec 31, 2023 | $16.06M | -57.7% |
| FY2022 | Dec 31, 2022 | $37.97M | -26.0% |
| FY2021 | Dec 31, 2021 | $51.31M | +10878.2% |
| FY2020 | Dec 31, 2020 | $467.34K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $36.54M | -53.9% |
| Q2 FY2026 | Jun 30, 2026 | $46.13M | -47.1% |
| Q1 FY2026 | Mar 31, 2026 | $58.86M | -36.7% |
| Q4 FY2025 | Dec 31, 2025 | $68.49M | -30.2% |
| Q3 FY2025 | Sep 30, 2025 | $79.23M | -8.2% |
| Q2 FY2025 | Jun 30, 2025 | $87.15M | -15.1% |
| Q1 FY2025 | Mar 31, 2025 | $92.97M | +741.2% |
| Q4 FY2024 | Dec 31, 2024 | $98.13M | +510.9% |
| Q3 FY2024 | Sep 30, 2024 | $86.33M | +275.5% |
| Q2 FY2024 | Jun 30, 2024 | $102.71M | +270.0% |
| Q1 FY2024 | Mar 31, 2024 | $11.05M | -65.4% |
| Q4 FY2023 | Dec 31, 2023 | $16.06M | -57.7% |
| Q3 FY2023 | Sep 30, 2023 | $22.99M | -45.4% |
| Q2 FY2023 | Jun 30, 2023 | $27.76M | -37.9% |
| Q1 FY2023 | Mar 31, 2023 | $31.97M | -32.0% |
| Q4 FY2022 | Dec 31, 2022 | $37.97M | -26.0% |
| Q3 FY2022 | Sep 30, 2022 | $42.08M | +1762.7% |
| Q2 FY2022 | Jun 30, 2022 | $44.70M | +9464.1% |
| Q1 FY2022 | Mar 31, 2022 | $47.03M | – |
| Q4 FY2021 | Dec 31, 2021 | $51.31M | – |
| Q3 FY2021 | Sep 30, 2021 | $2.26M | – |
| Q4 FY2020 | Dec 31, 2020 | $467.34K | – |
See a number that looks wrong?